Special Issue "Poultry Vaccines"
Deadline for manuscript submissions: 31 December 2021.
Interests: avian viral diseases; vaccines; vaccine development; avian respiratory diseases; viral immunosuppressive disease
Special Issues and Collections in MDPI journals
Interests: Vaccines; Vaccine development; Marek's Disease; Avian Metapneumovirus; Avian Coronavirus; infectious Bursal Disease; Newcastle Disease; Avian Viral respiratory and immunosuppressive Diseases
Special Issues and Collections in MDPI journals
the global market of vaccines for poultry accounted for total sales of many hundred million dollars in the last decade. Poultry vaccination is aimed not only to limit the occurrence of clinical diseases but also to reduce environmental infectious pressure and control the emergence and spread of epidemics, such as Avian Influenza. Today’s poultry industry is also asked to use vaccination as a tool to reduce the use of antibiotics, therefore contribute to the control of the occurrence of the antimicrobial resistance that is one of the biggest public health challenges of our time. Although vaccination is certainly of unequivocal advantage for the poultry system, vaccines failures can occur that demands the development of innovative preventive approaches. In this Special Issue, we invite original research and review papers that address recent advances in the field of poultry vaccines either for viral, bacterial and parasitic diseases. Topics of interest include but are not limited to: poultry vaccine basic science, manufacturing, technology, safety, and efficacy. Both experimental or field animal trials are welcomed. Specific topics may include diagnostic strategies to differentiate infected from vaccinated animals, identification of vaccine molecular markers, engineered vaccine development (e.g. vectored vaccines) and novel vaccine delivery tools.
Dr. Caterina Lupini
Dr. Elena Catelli
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- poultry vaccines
- avian diseases
- vaccine basic science
- engineered vaccine
- delivery tools
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Protection Conferred by Drinking Water Administration of a Nanoparticle-based Vaccine Against Salmonella Enteritidis in Hens
Authors: Javier Ochoa; Eduard Sebastiá; Ibai Tamayo; Juan Manuel Irache; Carlos Gamazo
Affiliation: Department of Microbiology, University of Navarra, 31008 Pamplona, Spain
Abstract: Abstract: Salmonella spp. infections transmitted by contaminated poultry and eggs represent a major global health burden. Salmonella enterica serovar. Enteritidis is the leading cause of human salmonellosis worldwide. The cell surface antigens of S. Enteritidis play an important role in the host-pathogen interactions and as such represent potential candidates for subunit-vaccine development. An immunogenic subcellular extract obtained from whole S. Enteritidis cells (HE) encapsulated in nanoparticles made with the polymer Gantrez (HE-NP) protected against lethal S. Enteritidis challenge in BALB/c mice. The oral vaccination of six week-old White Legorn hens was then investigated via drinking water containing HE-NP. When vaccinated at 6 and 9 weeks of age and then challenged at 12 weeks of age, a significant level of protection was elicited in the vaccinates when compared to the controls.